טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - glucose (monohydrate);;soybean oil ( eq to soya bean oil);;triglycerides medium chain;;olive oil;;fish-oil rich in omega-3 acids;;alanine;;arginine;;proline;;glycine (eq to aminoacetic acid)(eq to glycocoll);;lysine (acetate);;leucine;;serine;;valine;;sodium acetate (trihydrate);;phenylalanine;;isoleucine;;potassium chloride;;threonine;;methionine;;sodium glycerophosphate;;histidine;;magnesium sulfate anhydrous;;tryptophan;;taurine (eq to aminoethyl sulfonic acid );;calcium chloride (dihydrate);;tyrosine;;zinc sulfate anhydrous;;glucose;;alanine;;arginine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;histidine;;isoleucine;;leucine;;lysine;;methionine;;phenylalanine;;proline;;serine;;taurine (eq to aminoethyl sulfonic acid );;threonine;;tryptophan;;tyrosine;;valine;;calcium chloride dihydrate;;sodium glycerophosphate;;magnesium sulfate heptahydrate;;potassium chloride;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;zinc sulfate 7h2o;;soybean oil ( eq to soya bean oil);;triglycerides medium chain;;olive oil;;fish-oil rich in omega-3 acids - 注射劑 - glucose (monohydrate) (4020009760) (143)mg; soybean oil ( eq to soya bean oil) (4020001600) refinedmg; fish-oil rich in omega-3 acids (4020003620) mg; triglycerides medium chain (5640001102) mg; olive oil (9600021200) refinedmg; sodium acetate (trihydrate) (4008007670) (5.62)mg; potassium chloride (4012001800) mg; calcium chloride (dihydrate) (4012007350) (0.74)mg; alanine (4020100200) mg; arginine (4020100300) mg; histidine (4020100900) mg; isoleucine (4020101000) mg; leucine (4020101200) mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; tyrosine (4020102200) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; lysine (acetate) (4020191320) (9.3)mg; magnesium sulfate anhydrous (5612001550) (7h2o 2.47 )mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate (9200008500) anhydrousmg; zinc sulfate anhydrous (9200010660) (7h2o 23)mcg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; potassium chloride (4012001800) mg; glucose (4020000700) mg; soybean oil ( eq to soya bean oil) (4020001600) refinedmg; fish-oil rich in omega-3 acids (4020003620) mg; alanine (4020100200) mg; arginine (4020100300) mg; histidine (4020100900) mg; isoleucine (4020101000) mg; leucine (4020101200) mg; lysine (4020101300) mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; tyrosine (4020102200) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; magnesium sulfate heptahydrate (5612001582) mg; triglycerides medium chain (5640001102) mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; sodium glycerophosphate (9200008500) hydratemg; zinc sulfate 7h2o (9200010640) mg; olive oil (9600021200) refinedmg - combinations - 靜脈營養輸注，適用於無法由口腔進食或經腸道獲取足夠營養，或禁止由口腔及腸道進食之成年患者及2歲以上兒童。

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - glucose monohydrate;;purified structured triglyceride;;purified egg phospholipids;;alanine;;arginine;;proline;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-lysine acetate;;leucine;;serine;;valine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;phenylalanine;;isoleucine;;potassium chloride;;threonine;;methionine;;sodium glycerophosphate;;histidine;;tryptophan;;taurine (eq to 2-aminoethane sulfonic acid);;calcium chloride dihydrate;;tyrosine;;zinc sulfate 7h2o;;acetic acid glacial( eq to glacial acetic acid);;water for injection;;magnesium sulfate heptahydrate - 注射劑 - glucose monohydrate (4020000760) mg; purified egg phospholipids (9200006702) mg; purified structured triglyceride (9600053230) mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; potassium chloride (4012001800) mg; alanine (4020100200) mg; arginine (4020100300) mg; histidine (4020100900) mg; isoleucine (4020101000) mg; leucine (4020101200) mg; l-lysine acetate (4020101322) mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; tyrosine (4020102200) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; magnesium sulfate heptahydrate (5612001582) mg; taurine (eq to 2-aminoethane sulfonic acid) (9200000900) mg; sodium glycerophosphate (9200008500) mg; zinc sulfate 7h2o (9200010640) ug; acetic acid glacial( eq to glacial acetic acid) (9600000302) (q.s); water for injection (9604000900) ml - combinations - 經口或經腸營養無法進行、不足夠或禁忌的成年病患的非經腸營養。

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - glucose monohydrate;;purified structured triglyceride;;purified egg phospholipids;;l-alanine;;l-arginine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-histidine;;l-isoleucine;;l-leucine;;lysine acetate;;l-methionine;;l-phenylalanine;;l-proline;;l-serine;;taurine (eq to 2-aminoethane sulfonic acid);;l-threonine;;l-tryptophan;;l-tyrosine;;l-valine;;calcium chloride dihydrate;;magnesium sulfate 7h2o;;potassium chloride;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;zinc sulfate 7h2o;;sodium glycerophosphate anhydrous - 注射劑 - glucose monohydrate (4020000760) mg; purified egg phospholipids (9200006702) mg; purified structured triglyceride (9600053230) mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; potassium chloride (4012001800) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine acetate (4020101320) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; magnesium sulfate 7h2o (5612001580) mg; taurine (eq to 2-aminoethane sulfonic acid) (9200000900) mg; sodium glycerophosphate anhydrous (9200008520) mg; zinc sulfate 7h2o (9200010640) mg - combinations - 經口或經腸營養無法進行、不足夠或禁忌的成年病患的非經腸營養。

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣巴斯夫股份有限公司 台北市中山區松江路87號16樓 (23930512) - 原料藥粉末 - 局部止癢藥

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

嬌生股份有限公司 台北市大安區敦化南路二段319號4、5樓 (30814854) - nicotine - 吸入用液劑 - nicotine (9200006000) mg - nicotine - 戒菸輔助劑

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

輝凌藥品股份有限公司 台北市中山區松江路111號11樓 (86386138) - progesterone micronized - 陰道錠 - progesterone micronized (6832001110) mg - progesterone - 作為對不孕女性進行輔助生殖技術治療的一部分，用於黃體功能的補充。

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

裕利股份有限公司 臺北市松山區南京東路4段126號10樓、10樓之1至之3 (22853066) - felodipine - 持續性釋放錠 - felodipine (2412003300) 10mg - felodipine - 高血壓、心絞痛。

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

裕利股份有限公司 臺北市松山區南京東路4段126號10樓、10樓之1至之3 (22853066) - felodipine - 持續性釋放錠 - felodipine (2412003300) 5mg - felodipine - 高血壓、心絞痛。

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣阿斯特捷利康股份有限公司 台北市大安區敦化南路二段207號21樓 (16440975) - budesonide;;formoterol fumarate dihydrate - 粉狀吸入劑 - formoterol fumarate dihydrate (1216003030) mcg; budesonide (8406002100) mcg - formoterol and budesonide - １.氣喘 (asthma)適用於適合使用類固醇及長效β2作用劑（β2-agonist）合併治療的氣喘，以達到氣喘整體控制，包括預防、緩解症狀及降低惡化風險。２.慢性阻塞性肺部疾病 (copd)適用於18歲以上患有慢性阻塞性肺部疾病 (copd)，使用氣管擴張劑後之第一秒吐氣量 (post-bronchodilator fev1)少於預測值之70%，及已定期使用支氣管擴張劑而仍有惡化病史的病人之治療。

טייוואן - סינית - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣阿斯特捷利康股份有限公司 台北市大安區敦化南路二段207號21樓 (16440975) - acalabrutinib - 膠囊劑 - acalabrutinib (1013008800) mg - acalabrutinib - 1.先前曾接受至少一種治療的被套細胞淋巴瘤 (mantle cell lymphoma, mcl) 成年病人。2.慢性淋巴球性白血病 (chronic lymphocytic leukemia, cll) 或小淋巴球性淋巴瘤 (small lymphocytic lymphoma, sll) 成年病人。